| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.8853 | 
      | Human Intestinal Absorption | HIA+ | 0.5753 | 
      | Caco-2 Permeability | Caco2+ | 0.5377 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8493 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9875 | 
                                                     | Non-inhibitor | 0.9724 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9370 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.4840 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8271 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8894 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.8105 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8859 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8932 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9492 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9310 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9618 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9457 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9397 | 
                                                                    | Non-inhibitor | 0.9679 | 
      | AMES Toxicity | Non AMES toxic | 0.7670 | 
      | Carcinogens | Carcinogens  | 0.6211 | 
      | Fish Toxicity | Low FHMT | 0.9395 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.8085 | 
      | Honey Bee Toxicity | High HBT | 0.7000 | 
      | Biodegradation | Ready biodegradable | 0.8605 | 
      | Acute Oral Toxicity | III | 0.4528 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6498 |